Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenues	$ 106,207	$ 20,729
Cost of revenues	(18,233)	(26,754)
Gross profit (loss)	87,974	(6,025)
Operating expenses:
Research and development expenses (including amounts of related party of $246,260 and $375,193 for the three months ended March 31, 2025, and 2024, respectively)	1,724,084	2,084,648
Selling, general and administrative expenses	1,526,761	1,029,418
Total operating expenses	3,250,845	3,114,066
Loss from operations	(3,162,871)	(3,120,091)
Non-operating (expenses) income, net:
Interest expense	(180,445)	(48,696)
Issuance cost of senior secured convertible note measured at fair value		(138,992)
Fair value change for senior secured convertible note		(31,568)
Other income, net	57,294	24,537
Total non-operating expenses, net	(123,151)	(194,719)
Net loss before income taxes	(3,286,022)	(3,314,810)
Provision for income taxes
Net loss	$ (3,286,022)	$ (3,314,810)
Net loss per common share - basic	$ (0.21)	$ (0.57)
Net loss per common share - diluted	$ (0.21)	$ (0.57)
Weighted-average shares used in computing net loss per common share-basic	15,863,060	5,771,283
Weighted-average shares used in computing net loss per common share-diluted	15,863,060	5,771,283